OBJECTIVE: Bothrops venoms cause local edema, pain, hemorrhage and necrosis. In this study, we investigated the ability of Bothrops lanceolatus venom to cause edema in rat hind paws and examined the mediators involved. MATERIALS AND METHODS: Hind paw edema was induced in male Wister rats by the subplantar injection of venom (12.5-100 microg/paw) in the absence and presence of antagonists. Edema was quantified by hydroplethysmometry at 0.25, 0.5, 2, 4, 6 and 24 h post-injection and was expressed as the percentage increase relative to the contralateral (control) paw. The ability of the venom to release histamine from rat peritoneal mast cells was also assessed. RESULTS: Venom caused dose- and time-dependent edema that was maximal within 15 min but disappeared after 24 h and was accompanied by hemorrhage. Dexamethasone (1 mg/kg, s.c.), methysergide (6 mg/kg, i.p.), HOE 140 (0.6 mg/kg, i.v.) and mepyramine (6 mg/kg, i.p.) significantly ( p < 0.05) reduced edema formation, whereas indomethacin (10 mg/kg, i.p.) was ineffective. Dialysis did not affect venom-induced edema. Venom (1, 10 and 30 microg/ml) caused a concentration-dependent release of histamine (13 +/- 1%, 61.9 +/- 4.6% and 73.6 +/- 2.4%, respectively; n = 5) from rat peritoneal mast cells in vitro. Histological analysis confirmed the presence of edema, hemorrhage and neutrophil infiltration. Pretreating the venom with EDTA partially inhibited the edema and hemorrhage, but did not affect the migration of neutrophils. CONCLUSIONS: B. lanceolatus venom produced dose- and time-dependent edema in rat paws. This edema was not dependent on low molecular weight substances in the venom, but was partially dependent on a hemorrhagin and also involved the release of arachidonic acid metabolites, bradykinin, histamine and serotonin.
OBJECTIVE:Bothrops venoms cause local edema, pain, hemorrhage and necrosis. In this study, we investigated the ability of Bothrops lanceolatus venom to cause edema in rat hind paws and examined the mediators involved. MATERIALS AND METHODS: Hind paw edema was induced in male Wister rats by the subplantar injection of venom (12.5-100 microg/paw) in the absence and presence of antagonists. Edema was quantified by hydroplethysmometry at 0.25, 0.5, 2, 4, 6 and 24 h post-injection and was expressed as the percentage increase relative to the contralateral (control) paw. The ability of the venom to release histamine from rat peritoneal mast cells was also assessed. RESULTS: Venom caused dose- and time-dependent edema that was maximal within 15 min but disappeared after 24 h and was accompanied by hemorrhage. Dexamethasone (1 mg/kg, s.c.), methysergide (6 mg/kg, i.p.), HOE 140 (0.6 mg/kg, i.v.) and mepyramine (6 mg/kg, i.p.) significantly ( p < 0.05) reduced edema formation, whereas indomethacin (10 mg/kg, i.p.) was ineffective. Dialysis did not affect venom-induced edema. Venom (1, 10 and 30 microg/ml) caused a concentration-dependent release of histamine (13 +/- 1%, 61.9 +/- 4.6% and 73.6 +/- 2.4%, respectively; n = 5) from rat peritoneal mast cells in vitro. Histological analysis confirmed the presence of edema, hemorrhage and neutrophil infiltration. Pretreating the venom with EDTA partially inhibited the edema and hemorrhage, but did not affect the migration of neutrophils. CONCLUSIONS:B. lanceolatus venom produced dose- and time-dependent edema in rat paws. This edema was not dependent on low molecular weight substances in the venom, but was partially dependent on a hemorrhagin and also involved the release of arachidonic acid metabolites, bradykinin, histamine and serotonin.
Authors: Felipe Silva de França; Joel José Megale Gabrili; Laurence Mathieu; François Burgher; Joël Blomet; Denise V Tambourgi Journal: Arch Toxicol Date: 2021-01-04 Impact factor: 5.153
Authors: Viviana Alexandra Martínez-Villota; Paulo Francisco Mera-Martínez; José Darío Portillo-Miño Journal: Biomedica Date: 2022-03-01 Impact factor: 1.173
Authors: José Carlos Tavares Carvalho; Hady Keita; Giovanna Rocha Santana; Gisele Custódio de Souza; Igor Victor Ferreira Dos Santos; Jesus Rafael Rodriguez Amado; Ansoumane Kourouma; Ariadna Lafourcade Prada; Helison de Oliveira Carvalho; Maria Lúcia Silva Journal: Inflammopharmacology Date: 2017-05-17 Impact factor: 4.473
Authors: M Severyns; R Nevière; D Resiere; T Andriamananaivo; L Decaestecker; H Mehdaoui; G A Odri; J L Rouvillain Journal: Am J Trop Med Hyg Date: 2018-11 Impact factor: 2.345
Authors: N T Q Alves; R M Ximenes; R J B Jorge; J A M Silveira; J V A Santos; F A P Rodrigues; P H S Costa; F A F Xavier; J S A M Evangelista; A Havt; V C G Soares; M H Toyama; A N A Oliveira; R M Araújo; R S Alves; H S A Monteiro Journal: Braz J Med Biol Res Date: 2018-12-03 Impact factor: 2.590
Authors: Carlos At de Souza; Anderson M Kayano; Sulamita S Setúbal; Adriana S Pontes; Juliana L Furtado; Fábio H Kwasniewski; Kayena D Zaqueo; Andreimar M Soares; Rodrigo G Stábeli; Juliana P Zuliani Journal: J Venom Res Date: 2012-10-25